OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 97 filers reported holding OLEMA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,224,144 | +121.8% | 99,121 | +62.2% | 0.00% | – |
| Q2 2023 | $551,823 | -50.9% | 61,110 | -77.9% | 0.00% | – |
| Q2 2022 | $1,123,000 | -73.3% | 275,984 | -72.1% | 0.00% | -100.0% |
| Q1 2022 | $4,209,000 | -77.7% | 988,039 | -51.1% | 0.00% | -66.7% |
| Q4 2021 | $18,899,000 | -58.4% | 2,019,109 | +22.4% | 0.00% | -62.5% |
| Q3 2021 | $45,451,000 | +0.5% | 1,649,204 | +2.0% | 0.01% | 0.0% |
| Q2 2021 | $45,224,000 | -31.6% | 1,616,298 | -19.8% | 0.01% | -33.3% |
| Q1 2021 | $66,128,000 | -31.4% | 2,015,215 | -2.6% | 0.01% | -33.3% |
| Q4 2020 | $96,379,000 | – | 2,069,315 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 7,803,600 | $96,374,460 | 6.54% |
| Logos Global Management LP | 3,743,875 | $46,236,856 | 6.17% |
| MPM BioImpact LLC | 1,857,681 | $22,942,360 | 6.12% |
| Cormorant Asset Management, LP | 4,504,764 | $55,633,835 | 3.24% |
| BVF INC/IL | 9,135,893 | $112,828,279 | 3.04% |
| Vivo Capital, LLC | 1,873,704 | $23,140,244 | 2.54% |
| Altium Capital Management LP | 335,000 | $4,137,250 | 2.16% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 407,801 | $5,036,342 | 1.53% |
| HighVista Strategies LLC | 247,880 | $3,061,318 | 1.42% |
| ACUTA CAPITAL PARTNERS, LLC | 153,007 | $1,889,636 | 1.27% |